MBB Public Markets I LLC Takes Position in Mettler-Toledo International, Inc. $MTD

Key Points

• MBB Public Markets I LLC has acquired a new stake in Mettler-Toledo International, Inc., purchasing 261 shares valued at approximately $308,000 during the first quarter.
• Several hedge funds, including Farther Finance Advisors LLC and Wealth Enhancement Advisory Services LLC, significantly increased their stakes in Mettler-Toledo during the same period, with the majority of shares (95.07%) now owned by institutional investors.
• Analysts are optimistic about Mettler-Toledo's performance, with a consensus rating of "Moderate Buy" and a target price of $1,311.11, indicating confidence in the company's growth potential.

MBB Public Markets I LLC purchased a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 261 shares of the medical instruments supplier's stock, valued at approximately $308,000.

A number of other large investors have also recently bought and sold shares of MTD. Captrust Financial Advisors boosted its stake in Mettler-Toledo International by 11.6% during the 4th quarter. Captrust Financial Advisors now owns 656 shares of the medical instruments supplier's stock worth $802,000 after purchasing an additional 68 shares during the period. Cetera Investment Advisers raised its position in Mettler-Toledo International by 8.7% during the 4th quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier's stock worth $1,315,000 after buying an additional 86 shares during the last quarter. D. E. Shaw & Co. Inc. raised its position in Mettler-Toledo International by 212.0% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 10,192 shares of the medical instruments supplier's stock worth $12,472,000 after buying an additional 6,925 shares during the last quarter. Focus Partners Wealth raised its position in Mettler-Toledo International by 8.5% during the 4th quarter. Focus Partners Wealth now owns 1,721 shares of the medical instruments supplier's stock worth $2,106,000 after buying an additional 135 shares during the last quarter. Finally, Graham Capital Management L.P. purchased a new position in Mettler-Toledo International during the 4th quarter worth $683,000. Institutional investors and hedge funds own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have commented on MTD. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price objective for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Barclays began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Evercore ISI cut their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Citigroup increased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Finally, Robert W. Baird increased their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has an average rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Stock Performance

NYSE:MTD traded up $5.20 during mid-day trading on Tuesday, hitting $1,265.33. 26,234 shares of the company's stock traded hands, compared to its average volume of 168,407. The firm's 50 day simple moving average is $1,260.42 and its 200 day simple moving average is $1,184.76. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01. The company has a market cap of $26.07 billion, a PE ratio of 32.04, a price-to-earnings-growth ratio of 3.78 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same period last year, the company earned $9.65 EPS. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company's stock, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 over the last ninety days. Corporate insiders own 0.77% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.